Evaluación de la presencia de inmunidad humoral específica contra SARS-COV2 causante del covid-19 en hombres de la UPS Sede Quito en edades comprendidas entre 24 a 30 posterior al proceso de vacunación

Abstract

SARS-CoV2 is an emerging virus responsible for the respiratory disease known as COVID-19 that has managed to spread worldwide in a short period of time, for which accelerated vaccines have been developed that allow generating immunity against the virus to stop its expansion; that is why this research aims to evaluate the effect of vaccines in the male population of the Salesian Polytechnic University between 24 and 30 years old, through the application of rapid tests for the detection of obtained IgG and IgM, to determine the development of immunity in this population group after the vaccination process. For this study, capillary blood samples were taken and basic data of the participants such as age, sex, type of vaccination, vaccination time and the results obtained in the rapid tests were collected (positive IgG/IgM, negative IgM and IgG). The results in the analyzed sample indicate that there is a correlation between the presence and absence of IgG antibodies against SARS-CoV2 with the number of doses administered with a significance of 0.0169 in individuals with the three doses and the types of vaccines with a significance of 0.0331 in individuals with Sinovac.